What is the recommended empiric antimicrobial regimen and overall management for suspected perinatal infection in the mother (e.g., chorioamnionitis) and the newborn (e.g., early‑onset sepsis)?

Perinatal Infection Management

For suspected chorioamnionitis in the mother, initiate intravenous ampicillin 2g every 4 hours plus gentamicin 5-7 mg/kg every 24 hours immediately, adding clindamycin 900 mg every 8 hours or metronidazole at cord clamping if cesarean delivery is performed; for the newborn with maternal chorioamnionitis exposure, perform a limited evaluation (blood culture and CBC) and start empiric ampicillin plus gentamicin therapy pending culture results. 1, 2

Maternal Management: Chorioamnionitis

Empiric Antibiotic Regimen

The standard first-line treatment consists of:

• Ampicillin 2g IV loading dose, then 1g IV every 4 hours until delivery
• Gentamicin 5-7 mg/kg IV every 24 hours (note: recent CLSI guidelines recommend 7 mg/kg pulse dosing rather than 5 mg/kg) 1, 3

Critical addition for cesarean delivery: Add clindamycin 900 mg IV every 8 hours OR metronidazole at the time of umbilical cord clamping to provide anaerobic coverage 4, 5

Alternative Regimens

For penicillin-allergic patients:

• No history of anaphylaxis: Cefazolin 2g IV initial dose, then 1g IV every 8 hours 4
• High-risk anaphylaxis history: Vancomycin 1g IV every 12 hours plus gentamicin (or clindamycin 900 mg IV every 8 hours if susceptibility confirmed) 4

Important caveat: While CDC guidelines focus on GBS prophylaxis, broader spectrum agents are necessary for actual chorioamnionitis treatment 4. Recent evidence suggests ampicillin-tobramycin (with metronidazole for cesarean) reduces early-onset neonatal sepsis by 6.9% compared to ceftriaxone-metronidazole regimens 2.

Duration of Maternal Antibiotics

No additional postpartum antibiotics are necessary after vaginal or cesarean delivery once clinical improvement occurs 5. If postdelivery antibiotics are prescribed, one additional dose is supported by evidence, but routine continuation is not required 5.

Timing and Delivery Considerations

• Deliver promptly once chorioamnionitis is diagnosed, regardless of gestational age 5
• Do not delay delivery to complete corticosteroids or magnesium sulfate courses 5
• Vaginal delivery is preferred; cesarean delivery should be reserved for standard obstetrical indications 5
• The time interval from diagnosis to delivery does not significantly affect most maternal or neonatal outcomes 5

Newborn Management: Early-Onset Sepsis Risk

Risk Stratification Algorithm

Newborns with signs of sepsis (any gestational age):

• Full diagnostic evaluation: Blood culture, CBC with differential and platelets, chest radiograph if respiratory symptoms present, lumbar puncture if stable enough 4
• Immediate empiric therapy: IV ampicillin PLUS gentamicin (or alternative gram-negative coverage based on local resistance patterns) 4, 6

Well-appearing newborns with maternal chorioamnionitis:

• Limited evaluation: Blood culture at birth, CBC with differential and platelets (optimal timing: 6-12 hours after birth for improved sensitivity) 4, 1
• Empiric antibiotic therapy: IV ampicillin plus gentamicin pending culture results 1
• No lumbar puncture or chest radiograph needed unless clinical deterioration occurs 4

Well-appearing term newborns (≥37 weeks) with adequate maternal GBS prophylaxis (≥4 hours of penicillin/ampicillin/cefazolin):

• Observation only for ≥48 hours 4
• May discharge at 24 hours if all discharge criteria met, with follow-up within 48-72 hours 1

Well-appearing term newborns with inadequate/no maternal prophylaxis:

• ROM <18 hours: Observation for 48 hours only 1
• ROM ≥18 hours: Limited evaluation (blood culture, CBC) plus observation for ≥48 hours 1

All preterm infants (<37 weeks) with inadequate/no maternal prophylaxis:

• Limited evaluation (blood culture, CBC) plus observation for ≥48 hours 1

Neonatal Antibiotic Regimen

Standard empiric therapy:

• Ampicillin (dosing varies by gestational age and postnatal age) PLUS
• Gentamicin 4-5 mg/kg every 24-48 hours (depending on gestational age) 4, 6

This combination provides coverage for:

• Group B Streptococcus (GBS)
• Escherichia coli and other gram-negative pathogens
• Listeria monocytogenes

Duration: Discontinue antibiotics as soon as clinical course and laboratory evaluation exclude sepsis 1. For culture-negative cases with initial clinical concern, 48 hours of therapy is typically sufficient if the infant remains well-appearing.

Key Clinical Pitfalls

Avoid co-amoxiclav (amoxicillin-clavulanate) in the setting of preterm prelabor rupture of membranes, as it increases the risk of neonatal necrotizing enterocolitis 7.

Erythromycin is no longer acceptable for GBS prophylaxis in penicillin-allergic women at high risk for anaphylaxis 4.

Clindamycin or vancomycin alone (used for maternal GBS prophylaxis in penicillin-allergic women) are considered inadequate prophylaxis for neonatal management purposes; these infants require the same evaluation as those with no prophylaxis 1.

Consultation with obstetric providers is essential to determine the level of clinical suspicion for chorioamnionitis, as signs can be nonspecific 4.

The evidence strongly supports that maternal chorioamnionitis is an independent predictor of early-onset sepsis (OR 2.07,95% CI 1.85-5.08), with significantly higher incidence in exposed neonates (21% vs 8%) 8. However, chorioamnionitis does not significantly influence late-onset sepsis rates, which are driven by postnatal factors 8.